Nelarabine in Pediatric and Young Adult T-Cell Acute Lymphoblastic Leukemia-Clearly Beneficial?

J Clin Oncol. 2021 Feb 20;39(6):694. doi: 10.1200/JCO.20.02973. Epub 2021 Jan 14.

Authors

Anurag K Agrawal¹, Jennifer Michlitsch¹, Carla Golden¹, Caroline A Hastings¹, Robert Raphael¹, James H Feusner¹

Affiliation

¹ Anurag K. Agrawal, MD, Jennifer Michlitsch, MD, Carla Golden, MD, Caroline A. Hastings, MD, Robert Raphael, MD, and James H. Feusner, MD, Division of Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA.

PMID: 33444071
DOI: 10.1200/JCO.20.02973

No abstract available

Publication types

Letter
Comment

MeSH terms

Arabinonucleosides* / adverse effects
Child
Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
T-Lymphocytes
Young Adult

Substances

Arabinonucleosides
nelarabine